Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESMMO: Mycophenolate mofetil in high-grade locally advanced or metastatic osteosarcoma
TCTR20190701001Phase 2Completed
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mycophenolate mofetil in osteosarcoma (OS), sponsored by Faculty of Medicine, Chiang Mai University. Started Aug 2019; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on TCTR20190701001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190701001.